Page last updated: 2024-09-03

ginsenoside rh2 and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

ginsenoside rh2 has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

*Precursor T-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fang, B; Fang, J; Li, Y; Wang, M; Xia, T; Xu, B; Zhang, B; Zhang, J; Zhu, X1

Other Studies

1 other study(ies) available for ginsenoside rh2 and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
New insight into 20(S)-ginsenoside Rh2 against T-cell acute lymphoblastic leukemia associated with the gut microbiota and the immune system.
    European journal of medicinal chemistry, 2020, Oct-01, Volume: 203

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Gastrointestinal Microbiome; Ginsenosides; Homeostasis; Humans; Mice; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Xenograft Model Antitumor Assays

2020